在用塞米普利马布和维斯莫迪吉布治疗后,大基层瘤的完整反应

Jonathan Pirruccello1, Muhammad Zubair Afzal2, Mariana Voudouri3

  • 1Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA jonathan.pirruccello@hitchcock.org.

BMJ case reports
|July 14, 2023
PubMed
概括

这项案例研究表明,将塞米普利马布 (一种抗PD-1抗体) 与vismodegib结合起来,有效地治疗了严重的皮瘤. 患者实现了完全缓解,表明了对侵袭性皮肤癌的有前途的治疗方法.

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K